Bayesian Phase II Platform Trial Tests Novel Targeted Regimens for Brain Lymphoma
A multicentre phase II platform trial protocol establishes sequential testing of zanubrutinib monotherapy and combinations for relapsed primary central nervous ...
A multicentre phase II platform trial protocol establishes sequential testing of zanubrutinib monotherapy and combinations for relapsed primary central nervous ...
A retrospective study of 216 mantle cell lymphoma patients found disease progression within twelve months was associated with inferior subsequent ...
A retrospective cohort study found zanubrutinib was associated with reduced cardiotoxicity and lower rates of atrial fibrillation compared with chemoimmunotherapy ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.